On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era
Abstract Background Screening and treatment of hepatitis C virus (HCV) infection in people who use drugs (PWUD) remains insufficient. Reducing the burden of HCV infection in PWUD requires interventions focusing on the different steps of the HCV care cascade. Methods We performed a prospective, multi...
Saved in:
Main Authors: | Dana Busschots (Author), Rob Bielen (Author), Özgür M. Koc (Author), Leen Heyens (Author), Eefje Dercon (Author), Rita Verrando (Author), Filip Janssens (Author), Luc Van den Bergh (Author), Peter Van Lint (Author), Liesbeth Bruckers (Author), Frederik Nevens (Author), Geert Robaeys (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatitis C prevalence in incarcerated settings between 2013-2021: a systematic review and meta-analysis
by: Dana Busschots, et al.
Published: (2022) -
Hepatitis C reinfection in former and active injecting drug users in Belgium
by: Dana Busschots, et al.
Published: (2021) -
Identification and treatment of viral hepatitis C in persons who use drugs: a prospective, multicenter outreach study in Flanders, Belgium
by: Dana Busschots, et al.
Published: (2021) -
Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries
by: Rob Bielen, et al.
Published: (2018) -
Anti-HCV DAA are needed whatever liver fibrosis is. The cons
by: Pablo Barreiro
Published: (2016)